Inactive Instrument
CannaVEST Corp Stock OTC Bulletin Board
Stocks
US1376531018
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
OTC Bulletin Board
|
||
| - USD | - |
|
| Aug. 13 | CV Sciences, Inc., Q2 2026 Earnings Call, Aug 13, 2026 | |
| Aug. 13 | CV Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 2.85M 2.53M 2.36M 2.15M 4.06M 274M 4.09M 28.56M 11.07M 140M 10.68M 10.45M 449M | P/E 2024 |
-2.48x | P/E 2025 | -11.8x |
|---|---|---|---|---|---|
| Enterprise Value | 4.56M 4.05M 3.78M 3.45M 6.51M 439M 6.57M 45.8M 17.75M 224M 17.13M 16.76M 720M | EV / Sales 2024 |
0.42x | EV / Sales 2025 | 0.95x |
| Free-Float |
78.62% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: CannaVEST Corp
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 68 | 2018-05-30 |
Joerg Grasser
DFI | Director of Finance/CFO | 51 | 2019-03-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
BRD | Director/Board Member | 68 | 2018-05-30 |
Jamie Corroon
BRD | Director/Board Member | 56 | 2022-07-20 |
William McCorkle
BRD | Director/Board Member | 58 | 2022-10-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.61% | -3.43% | +39.40% | +112.31% | 1,019B | |
| -1.02% | -5.60% | +37.67% | +65.02% | 617B | |
| +1.11% | -0.58% | +11.10% | +77.28% | 464B | |
| +0.34% | -3.01% | +61.21% | +40.71% | 356B | |
| -0.95% | -4.05% | +21.60% | +39.37% | 333B | |
| -1.46% | -2.89% | +11.84% | +24.60% | 267B | |
| -1.35% | -5.43% | -4.69% | +8.40% | 244B | |
| -1.04% | -2.79% | +35.52% | +51.34% | 218B | |
| -1.87% | -4.10% | +30.92% | +95.33% | 179B | |
| Average | -0.23% | -3.39% | +27.17% | +57.15% | 410.8B | |
| Weighted average by Cap. | +0.42% | -3.33% | +30.52% | +68.96% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 15.7M 13.95M 13.02M 11.87M 22.39M 1.51B 22.6M 158M 61.07M 772M 58.96M 57.68M 2.48B | 13.79M 12.25M 11.43M 10.42M 19.66M 1.33B 19.84M 138M 53.62M 678M 51.77M 50.65M 2.17B |
| Net income | -2.39M -2.13M -1.99M -1.81M -3.41M -230M -3.44M -24.03M -9.31M -118M -8.99M -8.79M -378M | -958K -851K -794K -724K -1.37M -92.1M -1.38M -9.61M -3.73M -47.08M -3.6M -3.52M -151M |
| Net Debt | 325K 289K 270K 246K 463K 31.24M 468K 3.26M 1.26M 15.97M 1.22M 1.19M 51.26M | 1.72M 1.53M 1.42M 1.3M 2.45M 165M 2.47M 17.24M 6.68M 84.43M 6.45M 6.31M 271M |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
